Trodelvy is a biologic drug, which means it’s made from parts of living organisms. It doesn’t come in a biosimilar form. Biosimilars are like generic drugs. Unlike generics, which are made for ...

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer. The results of the TROPiCS ...

The reversal of fortunes for Gilead Sciences' Trodelvy in an advanced form of breast cancer is complete ... new market for the TROP2-targeting drug. On Friday, the FDA cleared Trodelvy ...